Dupilumab‐induced Urticaria-Reference-Cited by-同舟云学术

Dupilumab‐induced Urticaria

Published:2021-09-06 Issue:6 Volume:34 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Mastorino Luca¹^ORCID,Ortoncelli Michela¹,Virginia Bernardi²,Rolla Giovanni²^ORCID,Avallone Gianluca¹,Cavaliere Giovanni¹,Viola Riccardo¹,Quaglino Pietro¹,Ribero Simone¹^ORCID

Affiliation:

1. Dermatology Clinic, Department of Medical Sciences University of Turin Turin Italy

2. Allergy and Clinical Immunology Unit, Department of Medical Sciences University of Turin and Mauriziano Hospital Turin Italy

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.15117

Reference9 articles.

1. Dupilumab: First Global Approval

2. Dupilumab: A review of its use in the treatment of atopic dermatitis

3. Efficacy and safety of dupilumab monotherapy in adults with moderate-to-severe atopic dermatitis: a pooled analysis of two phase 3 randomized trials (LIBERTY AD SOLO 1 and LIBERTY AD SOLO 2)

4. Development or Exacerbation of Head and Neck Dermatitis in Patients Treated for Atopic Dermatitis With Dupilumab

5. Seborrhoeic dermatitis and sebopsoriasis developing in patients on dupilumab: Two case reports

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review of Dupilumab-Induced Adverse Events to Dermatologists and the Potential Pathogenesis in the Treatment of Atopic Dermatitis;Dermatitis®;2024-02-01

2. Immediate hypersensitivity to dupilumab: A French case series;The Journal of Allergy and Clinical Immunology: In Practice;2023-08

3. Pustular Psoriasis in a Patient Treated with Dupilumab for Atopic Dermatitis: A Case Report;Clinical, Cosmetic and Investigational Dermatology;2023-08

4. Dupilumab-induced pityriasis rosea;JAAD Case Reports;2023-03